A Report of a Rare Case of Hurthle Cell Carcinoma of Thyroid with Metachronous Renal Metastasis

Ritesh Kumar; Rituparna Biswas; Sandeep Mathur; Suman Bhasker; Nishikant Damle; CS Bal; Ekta Dhamija

doi:10.4103/ijmpo.ijmpo_147_18

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(03): 409-411
DOI: 10.4103/ijmpo.ijmpo_147_18

Practitioner Section

A Report of a Rare Case of Hurthle Cell Carcinoma of Thyroid with Metachronous Renal Metastasis

Ritesh Kumar

Department of Radiation Oncology, Dr. B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India

,

Rituparna Biswas

Department of Radiation Oncology, Dr. B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India

,

Sandeep Mathur

Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

,

Suman Bhasker

Department of Radiation Oncology, Dr. B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India

,

Nishikant Damle

Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India

,

CS Bal

Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India

,

Ekta Dhamija

Department of Radiology, Dr. B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India

› Author Affiliations

Abstract

Renal metastasis from Hurthle cell thyroid carcinoma is an extremely rare phenomenon which when present usually indicates widely disseminated disease. Herein, we present a case of Hurthle cell carcinoma of thyroid in a 58-year-old gentle lady, with metachronous renal metastasis which happens to be the fourth reported case in English literature.

Keywords

Follicular carcinoma - Hurthle cell - renal metastasis - thyroid malignancies

Full Text

References

References
1 Bhattacharyya N. Survival and prognosis in Hürthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg 2003; 129: 207-10
2 Djekidel M, Gordon M, Shah RB, Gross MD, Avram A. Renal metastasis from Hurthle cell thyroid carcinoma and its evaluation with hybrid imaging. Thyroid 2010; 20: 429-33
3 Zhang H, Zeng L, Liang C, Qiu H, Zhang M, Zhu Y. et al. Successful treatment of Hurthle cell thyroid carcinoma with lung and liver metastasis using docetaxel and cisplatin. Jpn J Clin Oncol 2012; 42: 1086-90
4 Claimon M, Suh M, Cheon GJ, Lee DS, Kim EE, Chung JK. et al. Bilateral renal metastasis of Hürthle cell thyroid cancer with discordant uptake between I-131 sodium iodide and F-18 FDG. Nucl Med Mol Imaging 2017; 51: 256-60
5 Besic N, Schwarzbartl-Pevec A, Vidergar-Kralj B, Crnic T, Gazic B, Marolt Music M. et al. Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: A single-institution experience. BMC Cancer 2016; 16: 162
6 Kushchayeva Y, Duh QY, Kebebew E, Clark OH. Prognostic indications for Hürthle cell cancer. World J Surg 2004; 28: 1266-70
7 Watson RG, Brennan MD, Goellner JR, van Heerden JR, McConahey WM, Taylor WF. et al. Invasive Hürthle cell carcinoma of the thyroid: Natural history and management. Mayo Clin Proc 1984; 59: 851-5
8 Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG. et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 2003; 97: 1186-94
9 Haugen BR, Sherman SI. Evolving approaches to patients with advanced differentiated thyroid cancer. Endocr Rev 2013; 34: 439-55